Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Cholera Vaccines Market Report 2016

  • QYR673159
  • 117 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Cholera Vaccines

Revenue, means the sales value of Cholera Vaccines

This report studies sales (consumption) of Cholera Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

ALK - Abello A/S (Denmark)

Altimmune, Inc. (US)

Bavarian Nordic A/S (Denmark)

BiondVax Pharmaceuticals Ltd. (Israel)

Bharat Biotech International Limited (India)

GlaxoSmithKline Plc. (UK)

Hualan Biological Engineering Inc. (China)

Janssen Pharmaceuticals, Inc. (US)

MedImmune (US)

Merck & Co., Inc. (US)

Pfizer Inc. (US)

Sanofi Pasteur SA (France)

Serum Institute of India Pvt. Ltd. (India)

Shanghai BravoBio Co., Ltd. (China)

Seqirus (UK)

SK Chemicals Co., Ltd. (Korea)

Takeda Pharmaceutical Company Limited (Japan)

Zydus Cadila (India)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Cholera Vaccines in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Cholera Vaccines Market Report 2016

1 Cholera Vaccines Overview

1.1 Product Overview and Scope of Cholera Vaccines

1.2 Classification of Cholera Vaccines

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Cholera Vaccines

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Cholera Vaccines (2011-2021)

1.4.1 USA Cholera Vaccines Sales and Growth Rate (2011-2021)

1.4.2 USA Cholera Vaccines Revenue and Growth Rate (2011-2021)

2 USA Cholera Vaccines Competition by Manufacturers

2.1 USA Cholera Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Cholera Vaccines Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Cholera Vaccines Average Price by Manufactures (2015 and 2016)

2.4 Cholera Vaccines Market Competitive Situation and Trends

2.4.1 Cholera Vaccines Market Concentration Rate

2.4.2 Cholera Vaccines Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Cholera Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Cholera Vaccines Sales and Market Share by Type (2011-2016)

3.2 USA Cholera Vaccines Revenue and Market Share by Type (2011-2016)

3.3 USA Cholera Vaccines Price by Type (2011-2016)

3.4 USA Cholera Vaccines Sales Growth Rate by Type (2011-2016)

4 USA Cholera Vaccines Sales (Volume) by Application (2011-2016)

4.1 USA Cholera Vaccines Sales and Market Share by Application (2011-2016)

4.2 USA Cholera Vaccines Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Cholera Vaccines Manufacturers Profiles/Analysis

5.1 ALK - Abello A/S (Denmark)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Cholera Vaccines Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 ALK - Abello A/S (Denmark) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Altimmune, Inc. (US)

5.2.2 Cholera Vaccines Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Altimmune, Inc. (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Bavarian Nordic A/S (Denmark)

5.3.2 Cholera Vaccines Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Bavarian Nordic A/S (Denmark) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 BiondVax Pharmaceuticals Ltd. (Israel)

5.4.2 Cholera Vaccines Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bharat Biotech International Limited (India)

5.5.2 Cholera Vaccines Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bharat Biotech International Limited (India) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 GlaxoSmithKline Plc. (UK)

5.6.2 Cholera Vaccines Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 GlaxoSmithKline Plc. (UK) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Hualan Biological Engineering Inc. (China)

5.7.2 Cholera Vaccines Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Hualan Biological Engineering Inc. (China) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Janssen Pharmaceuticals, Inc. (US)

5.8.2 Cholera Vaccines Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Janssen Pharmaceuticals, Inc. (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 MedImmune (US)

5.9.2 Cholera Vaccines Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 MedImmune (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Merck & Co., Inc. (US)

5.10.2 Cholera Vaccines Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Merck & Co., Inc. (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Pfizer Inc. (US)

5.12 Sanofi Pasteur SA (France)

5.13 Serum Institute of India Pvt. Ltd. (India)

5.14 Shanghai BravoBio Co., Ltd. (China)

5.15 Seqirus (UK)

5.16 SK Chemicals Co., Ltd. (Korea)

5.17 Takeda Pharmaceutical Company Limited (Japan)

5.18 Zydus Cadila (India)

6 Cholera Vaccines Manufacturing Cost Analysis

6.1 Cholera Vaccines Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Cholera Vaccines

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Cholera Vaccines Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Cholera Vaccines Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Cholera Vaccines Market Forecast (2016-2021)

10.1 USA Cholera Vaccines Sales, Revenue Forecast (2016-2021)

10.2 USA Cholera Vaccines Sales Forecast by Type (2016-2021)

10.3 USA Cholera Vaccines Sales Forecast by Application (2016-2021)

10.4 Cholera Vaccines Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Cholera Vaccines

Table Classification of Cholera Vaccines

Figure USA Sales Market Share of Cholera Vaccines by Type in 2015

Table Application of Cholera Vaccines

Figure USA Sales Market Share of Cholera Vaccines by Application in 2015

Figure USA Cholera Vaccines Sales and Growth Rate (2011-2021)

Figure USA Cholera Vaccines Revenue and Growth Rate (2011-2021)

Table USA Cholera Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA Cholera Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Cholera Vaccines Sales Share by Manufacturers

Figure 2016 Cholera Vaccines Sales Share by Manufacturers

Table USA Cholera Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA Cholera Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Cholera Vaccines Revenue Share by Manufacturers

Table 2016 USA Cholera Vaccines Revenue Share by Manufacturers

Table USA Market Cholera Vaccines Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Cholera Vaccines Average Price of Key Manufacturers in 2015

Figure Cholera Vaccines Market Share of Top 3 Manufacturers

Figure Cholera Vaccines Market Share of Top 5 Manufacturers

Table USA Cholera Vaccines Sales by Type (2011-2016)

Table USA Cholera Vaccines Sales Share by Type (2011-2016)

Figure USA Cholera Vaccines Sales Market Share by Type in 2015

Table USA Cholera Vaccines Revenue and Market Share by Type (2011-2016)

Table USA Cholera Vaccines Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Cholera Vaccines by Type (2011-2016)

Table USA Cholera Vaccines Price by Type (2011-2016)

Figure USA Cholera Vaccines Sales Growth Rate by Type (2011-2016)

Table USA Cholera Vaccines Sales by Application (2011-2016)

Table USA Cholera Vaccines Sales Market Share by Application (2011-2016)

Figure USA Cholera Vaccines Sales Market Share by Application in 2015

Table USA Cholera Vaccines Sales Growth Rate by Application (2011-2016)

Figure USA Cholera Vaccines Sales Growth Rate by Application (2011-2016)

Table ALK - Abello A/S (Denmark) Basic Information List

Table ALK - Abello A/S (Denmark) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ALK - Abello A/S (Denmark) Cholera Vaccines Sales Market Share (2011-2016)

Table Altimmune, Inc. (US) Basic Information List

Table Altimmune, Inc. (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Altimmune, Inc. (US) Cholera Vaccines Sales Market Share (2011-2016)

Table Bavarian Nordic A/S (Denmark) Basic Information List

Table Bavarian Nordic A/S (Denmark) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bavarian Nordic A/S (Denmark) Cholera Vaccines Sales Market Share (2011-2016)

Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List

Table BiondVax Pharmaceuticals Ltd. (Israel) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table BiondVax Pharmaceuticals Ltd. (Israel) Cholera Vaccines Sales Market Share (2011-2016)

Table Bharat Biotech International Limited (India) Basic Information List

Table Bharat Biotech International Limited (India) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bharat Biotech International Limited (India) Cholera Vaccines Sales Market Share (2011-2016)

Table GlaxoSmithKline Plc. (UK) Basic Information List

Table GlaxoSmithKline Plc. (UK) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Plc. (UK) Cholera Vaccines Sales Market Share (2011-2016)

Table Hualan Biological Engineering Inc. (China) Basic Information List

Table Hualan Biological Engineering Inc. (China) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hualan Biological Engineering Inc. (China) Cholera Vaccines Sales Market Share (2011-2016)

Table Janssen Pharmaceuticals, Inc. (US) Basic Information List

Table Janssen Pharmaceuticals, Inc. (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Pharmaceuticals, Inc. (US) Cholera Vaccines Sales Market Share (2011-2016)

Table MedImmune (US) Basic Information List

Table MedImmune (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table MedImmune (US) Cholera Vaccines Sales Market Share (2011-2016)

Table Merck & Co., Inc. (US) Basic Information List

Table Merck & Co., Inc. (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co., Inc. (US) Cholera Vaccines Sales Market Share (2011-2016)

Table Pfizer Inc. (US) Basic Information List

Table Pfizer Inc. (US) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Inc. (US) Cholera Vaccines Sales Market Share (2011-2016)

Table Sanofi Pasteur SA (France) Basic Information List

Table Sanofi Pasteur SA (France) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Pasteur SA (France) Cholera Vaccines Sales Market Share (2011-2016)

Table Serum Institute of India Pvt. Ltd. (India) Basic Information List

Table Serum Institute of India Pvt. Ltd. (India) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Serum Institute of India Pvt. Ltd. (India) Cholera Vaccines Sales Market Share (2011-2016)

Table Shanghai BravoBio Co., Ltd. (China) Basic Information List

Table Shanghai BravoBio Co., Ltd. (China) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shanghai BravoBio Co., Ltd. (China) Cholera Vaccines Sales Market Share (2011-2016)

Table Seqirus (UK) Basic Information List

Table Seqirus (UK) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Seqirus (UK) Cholera Vaccines Sales Market Share (2011-2016)

Table SK Chemicals Co., Ltd. (Korea) Basic Information List

Table SK Chemicals Co., Ltd. (Korea) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table SK Chemicals Co., Ltd. (Korea) Cholera Vaccines Sales Market Share (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List

Table Takeda Pharmaceutical Company Limited (Japan) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Cholera Vaccines Sales Market Share (2011-2016)

Table Zydus Cadila (India) Basic Information List

Table Zydus Cadila (India) Cholera Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zydus Cadila (India) Cholera Vaccines Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cholera Vaccines

Figure Manufacturing Process Analysis of Cholera Vaccines

Figure Cholera Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Cholera Vaccines Major Manufacturers in 2015

Table Major Buyers of Cholera Vaccines

Table Distributors/Traders List

Figure USA Cholera Vaccines Production and Growth Rate Forecast (2016-2021)

Figure USA Cholera Vaccines Revenue and Growth Rate Forecast (2016-2021)

Table USA Cholera Vaccines Production Forecast by Type (2016-2021)

Table USA Cholera Vaccines Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390